about
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockVentilator-associated pneumonia in the ICURecommendations for sepsis management in resource-limited settingsDescription and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse.Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.Development of an antibiotic spectrum score based on veterans affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: a modified Delphi approach.A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill PatientsFrequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges.Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare AdministrationTreatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Bloodstream infections in the Intensive Care Unit.Current management of sepsis in critically ill adult patients.Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.Antibiotic use in US hospitals: quantification, quality measures and stewardship.Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistancePiperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.Early management of sepsis.Update on surgical sepsis syndrome.Assessment of Rapid-Blood-Culture-Identification Result Interpretation and Antibiotic Prescribing Practices.De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study.Variability in Diagnosis and Treatment of Ventilator-Associated Pneumonia in Neurocritical Care Patients.Carbapenem de-escalation therapy in a resource-limited setting.Infection control team activity and recent antibiograms in the Kobe University Hospital.The case for de-escalation in antimicrobial therapy: time to change our strategy in the management of septic shock?Stability of amoxicillin and amoxicillin/clavulanic acid reconstituted in isotonic saline.The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record.The knowledge, attitudes and practices of doctors regarding antibiotic resistance at a tertiary care institution in the Caribbean.Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study.Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
P2860
Q24198268-31262245-2847-4DCF-B1E8-60EE73383B6DQ26862843-207EE7B9-CDAA-4CD7-99D2-F5F0DE7D9393Q30511819-B86C2D43-C572-4314-B07C-E742D7B608E9Q30647100-10C62E20-9B57-463E-A016-10FFE775CA16Q33863124-9990C8EB-92BD-4994-ABF2-E8965628D37DQ33925668-D122FF83-54C8-486F-960E-522E5B46713DQ35222958-E3895D65-7BCD-4F91-A6F5-FFE62951B553Q35860038-6C753E6C-FD4F-4DBC-9249-20A7D98A2076Q36220740-6C2F86A2-4681-47A0-899A-3761F397FD06Q36281234-AD5EE203-4B14-4C20-A52F-9D934C35D04EQ36294413-44014975-BC10-4DDC-B9BB-4D0BFE690EC8Q36331033-FAF1E4DA-0D83-40D4-BBC1-0A459C18B3B5Q36455347-741B0E10-41BE-4744-A1FE-9FAC627ABA0EQ36517624-36BAA751-6E57-44AE-998C-77CE34693E88Q36913336-93A64A0D-DE12-4062-95C0-5EF7C6A6F7CEQ37910252-0DDC0D4C-E6F8-4395-A05D-455DD337D982Q37915360-5CBF2FAF-B189-4D6E-BEC2-FCAD11527C87Q37993713-79FE1629-252D-4730-81B5-97C0A72A419EQ38449948-D504549D-3536-40E8-A792-A5E24409C66CQ38512609-AA8899BF-2534-4C83-B489-59CCAA3CD8C2Q38592896-99E78C8B-E155-478E-B787-04A70BF9CC2CQ38983475-F2E8DF8E-3575-4749-BB6E-06837276F906Q39102556-52390CB1-6CC7-4619-AE02-5F98335B1869Q40312363-ED5D62B3-388F-425F-B6F7-FFDBE87C4EBBQ40540723-F89EA5CC-DD18-4E8D-9C60-099B979DC887Q41507634-D6EF3575-B05E-4DC5-8A44-754EECCE3D9BQ42240855-DF634A77-35F8-4ADA-A53F-1718B2FD3054Q42264706-2DBC943A-681B-48FA-8C96-ABC1AD8CCBDCQ45049663-3FCF0172-3365-40A9-B75D-9FB55FD7AF29Q49135085-6DC42BBC-40BA-402E-A290-5DC290BB2804Q50141533-38A47945-50B6-4CE0-B0F7-12DEC0DFB4C3Q50190115-B4CD354B-B458-49B3-9B6F-0E8907E3FBCDQ55467877-8BB386FC-B7ED-4570-A227-228C7F5B5440Q59135453-EFA24958-598C-45BE-AE7E-DEC11CC660F0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibiotic de-escalation.
@en
Antibiotic de-escalation.
@nl
type
label
Antibiotic de-escalation.
@en
Antibiotic de-escalation.
@nl
prefLabel
Antibiotic de-escalation.
@en
Antibiotic de-escalation.
@nl
P1476
Antibiotic de-escalation.
@en
P2093
Robert G Masterton
P304
P356
10.1016/J.CCC.2010.09.009
P577
2011-01-01T00:00:00Z